Search bioRxiv⌕ Search

Biology subjects

MAS, C.

Publications and source records attributed to MAS, C..

3 recordsLinked to original sources

Assembly of the essential SpoIVA coat protein at the surface of developing bacterial spores

Bacterial spores owe their remarkable resistance properties to a multilayered coat, one of the most resilient and durable biological structures on Earth. Assembled at the surface of the outer forespore membrane, the coat comprises dozens of proteins organized into distinct layers. Its formation is initiated by SpoIVA, which is proposed to form a polymeric scaffold for the innermost coat layer. Although SpoIVA has been shown to polymerize into filaments in vitro, there is currently no evidence demonstrating the formation of such assemblies in vivo, and the mechanism underlying its oligomerization remains unresolved. In this study, cryo-focused ion beam milling combined with cryo-electron tomography of sporulating Bacillus subtilis cells reveals that the SpoIVA layer consists of polymers that form track-like structures radiating from the mother cell-proximal forespore pole and extending directionally toward the distal pole. Subtomogram averaging further sheds light on their organized architecture, harboring a straight orientation, uniform spacing, and embedding in the outer forespore membrane. These observations also define SpoIVA spatial orientation relative to the outer forespore membrane. Furthermore, AlphaFold3 predictions, combined with biophysical and functional assays, show that SpoIVA dimerizes through its central and C-terminal regions. We further show that dimerization promotes SpoIVA localization around the forespore but is dispensable for polymer formation, which relies on the ATPase domain. Altogether, these findings suggest a dual oligomerization mechanism, in which SpoIVA transitions from dimers to linear track-like polymers, and reveal that these assemblies play critical roles in coat assembly and spore development.

microbiology↗

A drug repurposing screen identifies altiratinib as a selective inhibitor of a key regulatory splicing kinase and a potential therapeutic for toxoplasmosis and malaria

Introductory paragraphThe apicomplexa comprise a large phylum of single-celled, obligate intracellular protozoa that infect humans and animals and cause severe parasitic diseases. Available therapeutics against these devastating diseases are limited by suboptimal efficacy and frequent side effects, as well as the emergence and spread of resistance. Here, we use a drug repurposing strategy and identify altiratinib, a compound originally developed to treat glioblastoma, as a promising drug candidate with broad spectrum activity against apicomplexans. Altiratinib is parasiticidal and blocks the development of intracellular zoites in the nanomolar range and with a high selectivity index. We have identified TgPRP4K of T. gondii as the primary target of altiratinib by genetic target deconvolution, highlighting key residues within the kinase catalytic site that, when mutated, confer resistance to the drug. We have further elucidated the molecular basis of the inhibitory mechanism and species selectivity of altiratinib for TgPRP4K as well as for its P. falciparum counterpart PfCLK3. Our data also point to structural features critical for binding of the other PfCLK3 inhibitor, TCMDC-135051. Consistent with the role of this kinase family in splicing in a broad spectrum of eukaryotes, we have shown that altiratinib causes global disruption of splicing, primarily through intron retention in both T. gondii and P. falciparum. Thus, our data establish parasitic PRP4K/CLK3 as a promising pan-apicomplexan target whose repertoire of inhibitors can be expanded by the addition of altiratinib.

microbiology↗

A plant-like mechanism coupling m6A reading to polyadenylation safeguards transcriptome integrity and developmental genes partitioning in Toxoplasma

Correct 3end processing of mRNAs is regarded as one of the regulatory cornerstones of gene expression. In a parasite that must answer to the high regulatory requirements of its multi-host life style, there is a great need to adopt additional means to partition the distinct transcriptional signatures of the closely and tandemly-arranged stage specific genes. In this study, we report on our findings in T. gondii of an m6A-dependent 3end polyadenylation serving as a transcriptional barrier at these loci. We identify the core polyadenylation complex within T. gondii and establish CPSF4 as a reader for m6A-modified mRNAs, via a YTH domain within its C-terminus, a feature which is shared with plants. We bring evidence of the specificity of this interaction both biochemically, and by determining the crystal structure at high resolution of the T. gondii CPSF4-YTH in complex with an m6A modified RNA. We show that the loss of m6A, both at the level of its deposition or its recognition was associated with an increase in aberrantly elongated chimeric mRNAs emanating from impaired transcriptional termination, a phenotype previously noticed in the plant model Arabidopsis thaliana. We bring Nanopore direct RNA sequencing-based evidence of the occurrence of transcriptional read-through breaching into downstream repressed stage-specific genes, in the absence of either CPSF4 or the m6A RNA methylase components in both T. gondii and A. thaliana. Taken together, our results shed light on an essential regulatory mechanism coupling the pathways of m6A metabolism directly to the cleavage and polyadenylation processes, one that interestingly seem to serve, in both T. gondii and A. thaliana, as a guardian against aberrant transcriptional read-throughs. HighlightsO_LIm6A is recognized in apicomplexan and plants by CPSF4, a member of the cleavage and polyadenylation complex machinery. C_LIO_LIThe structural insight behind the specificity of the binding of m6A by the CPSF4 YTH subunit are solved by high resolution crystal structures. C_LIO_LIThe m6A-driven 3end polyadenylation pathway protects transcriptome integrity by restricting transcriptional read-throughs and RNA chimera formation in apicomplexan parasites and plants. C_LI

microbiology↗